Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;14(2):99-104.
doi: 10.1007/BF00200176.

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

G Fossati  1 , A Balsari, D Taramelli, M L Sensi, G Pellegris, M Nava, G Parmiani
Affiliations

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

G Fossati et al. Cancer Immunol Immunother. 1982.

Abstract

Peripheral blood lymphocytes (PBL) of melanoma patients were sensitized in vitro with lymphocytes of a single donor or with a pool of lymphocytes of 5-20 different donors. After 6-7 days, the cytotoxic activity of the sensitized PBL was tested against cultured autologous tumor cells and lymphocytes in a 51Cr-release assay. Tumor lysis was observed in 13 of 16 cases in which patients' PBL (Pt-PBL) were stimulated by a pool of allogeneic lymphocytes and in five out of seven cases when single sensitization was performed. In no case was lysis of autologous normal lymphocytes or blasts seen. Cultivation of Pt-PBL with irradiated autologous tumor cells never led to the induction of lymphocytes cytotoxic to melanoma cells. Lysability by pool-activated autologous Pt-PBL of fresh cryopreserved tumor cells was compared to that of short-term cultured tumor cells, and no significant differences were observed. Cold-target inhibition experiments indicated that the cytotoxicity of Pt-PBL was tumor-restricted since only autologous melanoma cells but not lymphocytes were able to inhibit the reaction. These results indicate that activation of Pt-PBL is necessary in order to elicit or amplify their antitumor activity.

PubMed Disclaimer

References

    1. Bach FH, Leshem B, Kuperman OJ, Bunzendhal H, Alter BJ, Zarling JM. Allosensitization to obtain anti-tumor immunity. In: Fefer A, Goldstein AM, editors. The Potential Role of T Cells Subpopulations in Cancer Therapy. New York: Raven Press; 1982.
    1. Du Pont G, Alexander M, Zehngebot L, Mitchell K, Herlyn M. Primary melanoma induces HLA-DR dependent autologous T-cell proliferation. Proc Am Ass Cancer Res. 1982;23:1076.
    1. Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2. Int J Cancer. 1981;28:695. - PubMed
    1. Kedar E, Herberman RB. Induction of NK-like anti-tumor reactivity in vitro and in vivo by IL-2. In: Herberman RB, editor. Natural Cell-Mediated Immunity, vol 2. New York: Academic Press; 1982. p. 859.
    1. Landazuri OM, Herberman RB. Specificity of cellular immune reactivity to virus induced tumors. Nature. 1972;238:18. - PubMed

Publication types

LinkOut - more resources